|Day Low/High||5.68 / 5.99|
|52 Wk Low/High||5.61 / 18.60|
Combination of TGR-1202 + Ibrutinib appears well-tolerated and active in relapsed/refractory CLL patients treated with the combination
Presentation Scheduled for Friday June 10, 2016 at 10:00am ET
Trade-Ideas LLC identified TG Therapeutics (TGTX) as a weak on high relative volume candidate
Updates on smaller housing, retail and biotech plays recently mentioned on these pages.
Investor Reception to be Held on Monday June 6, 2016 at 7:00pm CT at the Peninsula Chicago Hotel with Presentations by Leading Clinical Investigators
Presentations demonstrate the safety and efficacy of TGR-1202 in combination with ublituximab as well as in combination with ibrutinib in patients with CLL and NHL
An integrated-analysis of the long term follow up of TGR-1202 monotherapy and in combination with TG-1101 (ublituximab) to be featured in a poster presentation and discussion session
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Don't trade the headline numbers, but cash in on those traders that do.
Investor Conference Call to be Held Today, Tuesday, May 10, 2016 at 4:30pm ET
Investor Conference Call to be held Tuesday, May 10, 2016 at 4:30pm ET
Cramer likes Constellation Brands over Boston Beer and admits he's been wrong before on Fitbit.
You could focus on Apple's disappointing quarter but just about everything else outside of tech stocks is heading higher, Cramer says.
Investors considering a purchase of TG Therapeutics Inc stock, but cautious about paying the going market price of $10.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.
Stocks with insider trader activity include BLOX, ILMN and TGTX
Patent protection for TG-1101 in the US through mid-2029
These stocks trading for less than $10 a share are within range of triggering big breakout trades.
Early data begins to elucidate mechanism for differentiated safety profile observed to date for TGR-1202
Presentation Scheduled for Tuesday March 15, 2016 at 3:30pm PT
Investor Conference Call to be Held Monday, March 7, 2016 at 4:30pm ET
Patent Protection for TGR-1202 in the US Through July of 2033, Exclusive of Patent Term Extensions